| Title: | GWAS of extended prescription analgesic use identifies genetic loci in chronic pain |
| Journal: | Nature Communications |
| Published: | 28 May 2026 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/42209495/ |
| DOI: | https://doi.org/10.1038/s41467-026-71434-8 |
| URL: | https://www.nature.com/articles/s41467-026-71434-8_reference.pdf |
Publication 19880
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Pain-related conditions are the leading cause of disability worldwide. Existing GWAS for chronic pain have mainly focused on individual pain-related disorders, which may not optimally capture the phenotype. Here, we define chronic pain based on prescription analgesic use ( ≥ 90 days) in two large biobanks (UK Biobank and FinnGen). GWAS meta-analyses of 11 prescription-based pain phenotypes identify 140 associations with chronic pain, including 78 novel (e.g. ARPP21, CNTNAP2) and 62 previously reported (e.g. SLC39A8, DCC, TRPM8) associations. Integrating these genetic associations with functional data including transcriptome-wide association studies, cell-type and pathway enrichment, and gene enrichment in mouse phenotypes identifies potential mechanisms involved in chronic pain, implicating oligodendrocyte differentiation, neuronal guidance, endolysosomal function and post-synaptic endosome recycling. Our study showcases how the use of prescription data to identify and characterize pain can provide insights into pain genetics and its underlying biology.</p>
21 Authors
- Charli E. Harlow
- Emeka Uzochukwu
- Hazel A. Fernando
- Charles E. Mordaunt
- Jordan M. Hughey
- John D. Eicher
- Lara Robinson
- Nicholas Bowker
- Laurence Howe
- Jimmy Liu
- Adrian Cortes
- Paul Wilson
- Usha Gungabissoon
- Victoria S. Benson
- Anthony Nash
- Gareth Young
- Laura Addis
- Chun-Fang Xu
- Caleb Webber
- Jonathan Davitte
- M. Zameel Cader
1 Application
| Application ID | Title |
|---|---|
| 20361 | Comprehensive Phenotype-wide Association Studies (PheWAS)for Genetic Tool Variants relevant to GSK Drug Targets |
Enabling scientific discoveries that improve human health